Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000988,WF.BBDR-(D4Got39-D4Rat44)/Wor,not specified,72 days to 68 days,10,,CMO:0001582,post-insult time to onset of diabetes mellitus,,onset of experimental diabetes mellitus,,17,d,,,MMO:0000112,blood glucose analysis,,0.0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66156,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000991,WF.BBDR-(D4Rat96-D4Rat44)/Wor,not specified,72 days to 68 days,12,,CMO:0001582,post-insult time to onset of diabetes mellitus,,,,24,d,,,MMO:0000112,blood glucose analysis,,0.0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66158,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000985,WF.BBDR-(D4Arb29-D4Rat265)/Wor,not specified,72 days to 68 days,5,,CMO:0001582,post-insult time to onset of diabetes mellitus,,,,30,d,,,MMO:0000112,blood glucose analysis,,0.0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66162,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000987,WF.BBDR-(D4Arb29-D4Rat96)/Wor,not specified,72 days to 68 days,10,,CMO:0001582,post-insult time to onset of diabetes mellitus,,,,30,d,,,MMO:0000112,blood glucose analysis,,0.0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66164,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000986,WF.BBDR-(D4Arb29-D4Rat44)/Wor,not specified,72 days to 68 days,18,,CMO:0001582,post-insult time to onset of diabetes mellitus,,,,20,d,,,MMO:0000112,blood glucose analysis,,0.0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66165,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 711,"Martin AM, et al., Diabetes 1999 Nov;48(11):2138-44",glucose metabolism trait,,RS:0000073,BBDR/Rhw,not specified,70 days to 0 days,12,,CMO:0001582,post-insult time to onset of diabetes mellitus,,,,11,d,1.0,3.4641,MMO:0000112,blood glucose analysis,,0.0,anti-RT6.1mAB and poly I:C,injection,,,anti-RT6.1 antibody (2 ml) (for 28 days) and Poly I:C (5 ug/g) (for 28 days),66148,anti-RT6.1 antibody (2 ml) (for 28 days),Poly I:C (5 ug/g) (for 28 days) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000988,WF.BBDR-(D4Got39-D4Rat44)/Wor,not specified,72 days to 68 days,10,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,incidence of experimental diabetes mellitus,,30,%,,,MMO:0000112,blood glucose analysis,,0.0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66154,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000989,WF.BBDR-(D4Got51-D4Rat44)/Wor,not specified,72 days to 68 days,12,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,0,%,,,MMO:0000112,blood glucose analysis,,0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66155,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000991,WF.BBDR-(D4Rat96-D4Rat44)/Wor,not specified,72 days to 68 days,12,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,58,%,,,MMO:0000112,blood glucose analysis,,0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66157,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000986,WF.BBDR-(D4Arb29-D4Rat44)/Wor,not specified,72 days to 68 days,18,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,39,%,,,MMO:0000112,blood glucose analysis,,0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66159,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000990,WF.BBDR-(D4Rat16-D4Got39)/Wor,not specified,72 days to 68 days,4,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,0,%,,,MMO:0000112,blood glucose analysis,,0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66160,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000985,WF.BBDR-(D4Arb29-D4Rat265)/Wor,not specified,72 days to 68 days,5,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,40,%,,,MMO:0000112,blood glucose analysis,,0.0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66161,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 714,"Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.",glucose metabolism trait,,RS:0000987,WF.BBDR-(D4Arb29-D4Rat96)/Wor,not specified,72 days to 68 days,10,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,20,%,,,MMO:0000112,blood glucose analysis,,0.0,anti-ART2.1mAB and poly I:C,,,,anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g) ,66163,anti-RT6.1 antibody (1 ml) ,Poly I:C (2.5 ug/g) 711,"Martin AM, et al., Diabetes 1999 Nov;48(11):2138-44",glucose metabolism trait,,RS:0000073,BBDR/Rhw,not specified,70 days to 0 days,12,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,100,%,,,MMO:0000112,blood glucose analysis,,0.0,anti-RT6.1mAB and poly I:C,injection,,,anti-RT6.1 antibody (2 ml) (for 28 days) and Poly I:C (5 ug/g) (for 28 days),66147,anti-RT6.1 antibody (2 ml) (for 28 days),Poly I:C (5 ug/g) (for 28 days) 715,"Blankenhorn EP, et al., Ann N Y Acad Sci. 2007 Mar 21;.",glucose metabolism trait,,RS:0000991,WF.BBDR-(D4Rat96-D4Rat44)/Wor,not specified,72 days to 68 days,N/A,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,58,%,,,MMO:0000112,blood glucose analysis,,0.0,,injection,,,anti-RT6.1 antibody (for 30 days) and Poly I:C (2.5 ug/g) (for 30 days),66166,anti-RT6.1 antibody (for 30 days),Poly I:C (2.5 ug/g) (for 30 days) 715,"Blankenhorn EP, et al., Ann N Y Acad Sci. 2007 Mar 21;.",glucose metabolism trait,,RS:0001580,WF.BBDR-(D4Got48-D4Got43)/Wor,not specified,72 days to 68 days,N/A,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,13,%,,,MMO:0000112,blood glucose analysis,,0,,injection,,,anti-RT6.1 antibody (for 30 days) and Poly I:C (2.5 ug/g) (for 30 days),66167,anti-RT6.1 antibody (for 30 days),Poly I:C (2.5 ug/g) (for 30 days) 715,"Blankenhorn EP, et al., Ann N Y Acad Sci. 2007 Mar 21;.",glucose metabolism trait,,RS:0001581,WF.BBDR-(D4Rat93-D4Rat228)/Wor,not specified,72 days to 68 days,N/A,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,52,%,,,MMO:0000112,blood glucose analysis,,0,,injection,,,anti-RT6.1 antibody (for 30 days) and Poly I:C (2.5 ug/g) (for 30 days),66168,anti-RT6.1 antibody (for 30 days),Poly I:C (2.5 ug/g) (for 30 days) 715,"Blankenhorn EP, et al., Ann N Y Acad Sci. 2007 Mar 21;.",glucose metabolism trait,,RS:0001579,WF.BBDR-(Clcn1-D4Rat228)/Wor,not specified,72 days to 68 days,N/A,,CMO:0001136,percentage of study population developing type 1 diabetes mellitus during a period of time,,,,0,%,,,MMO:0000112,blood glucose analysis,,0,,injection,,,anti-RT6.1 antibody (for 30 days) and Poly I:C (2.5 ug/g) (for 30 days),66169,anti-RT6.1 antibody (for 30 days),Poly I:C (2.5 ug/g) (for 30 days) 1010,"Blankenhorn EP, et al., Diabetes 2005 Apr;54(4):1233-7.",glucose metabolism trait,,RS:0000076,BBDR/Wor,both,0 days to 21 days,12,,CMO:0001114,percentage of study population developing diabetes mellitus during a period of time,,,,100,%,,,MMO:0000165,blood glucose test strip read by electrochemical glucometer,,0.0,,,,,Poly I:C (1 ug/g) (for 40 days) and anti-RT6.1 antibody (25 ug) (for 40 days),68796,Poly I:C (1 ug/g) (for 40 days),anti-RT6.1 antibody (25 ug) (for 40 days) 1010,"Blankenhorn EP, et al., Diabetes 2005 Apr;54(4):1233-7.",glucose metabolism trait,,RS:0000992,WF.BBDR-ART2a/Wor,both,0 days to 21 days,53,,CMO:0001114,percentage of study population developing diabetes mellitus during a period of time,,,,0.1,%,,,MMO:0000165,blood glucose test strip read by electrochemical glucometer,,0.0,,,,,Poly I:C (1 ug/g) (for 40 days) and anti-RT6.1 antibody (25 ug) (for 40 days),68800,Poly I:C (1 ug/g) (for 40 days),anti-RT6.1 antibody (25 ug) (for 40 days) 1010,"Blankenhorn EP, et al., Diabetes 2005 Apr;54(4):1233-7.",glucose metabolism trait,,RS:0000989,WF.BBDR-(D4Got51-D4Rat44)/Wor,both,0 days to 21 days,12,,CMO:0001114,percentage of study population developing diabetes mellitus during a period of time,,,,0.6,%,,,MMO:0000165,blood glucose test strip read by electrochemical glucometer,,0.0,,,,,Poly I:C (1 ug/g) (for 40 days) and anti-RT6.1 antibody (25 ug) (for 40 days),69367,Poly I:C (1 ug/g) (for 40 days),anti-RT6.1 antibody (25 ug) (for 40 days)